national

Japan to launch infectious diseases databank to fight COVID-19

29 Comments

The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.

© KYODO

©2024 GPlusMedia Inc.

29 Comments
Login to comment

starting with a plan to collect data on 10,000 COVID-19 patients by next March, 

Will only take 2+years after the emergence of Covid and millions infected worldwide to get the ball rolling on researching this virus in Japan with a whopping 10,000 samples.

Happy to see a sense of urgency!

14 ( +16 / -2 )

No emergency. No urgency.

-1 ( +6 / -7 )

Pure theater!

Millions of people packed onto trains and in stations and underground walkways and collecting samples is the way to ‘fight’ the infection?

7 ( +9 / -2 )

The database will be up and working just in time to have all that information already available (and acted upon) from several international sources, maybe even after the pandemic already stopped being a priority around the world.

6 ( +9 / -3 )

yawn- another useless measure by an equally useless gov

7 ( +8 / -1 )

Oh goodie... another government database to collect and abuse private citizens data. Want a vaccine passport? Sorry you are not in the voluntary Covid database. Want health benefits? Sorry you are not in the voluntary Covid database. Etc. etc. Wonder how long it will take the hackers to get the entire thing up on the dark web?

2 ( +5 / -3 )

It's taken about a year to arrive at this decision, which is not final, so at least another year of meetings, lol you have to love the J Gov

8 ( +9 / -1 )

And with the stigma of infection here, expect 10,000 people to step forward enthusiastically!

5 ( +6 / -1 )

It won’t be very comprehensive since Japan doesn’t do contact tracing.

4 ( +5 / -1 )

It's gonna be a huge Excel file in a shared drive.

6 ( +7 / -1 )

to help firms and universities develop treatments amid the pandemic, project members said Wednesday.

There already are treatments that are successful in curing covid. Ivermectin and Hydroxychloroquine. The shame of it all is that Ivermectin was invented by a Japanese Scientist who received the Noble Peace Prize for it. It is being used successfully in several Indian states with enormous success. Watch certain vaccine promoters do a bunk on what I have written. The use of these anti-parasite medicines would have ensured the Olympics to be held with no problem.

-8 ( +2 / -10 )

That is false, HCQ has already been completely proved useless against COVID and the report that first supposedly showed an effect a scam product of manipulation and fabrication of the data. Ivermectin has been plagued by conflicting evidence (including some reports of it being useless) so it required huge clinical trials to decide if it actually have any effect, no hard evidence of it being actually beneficial even on India.

https://healthfeedback.org/claimreview/no-data-available-to-suggest-a-link-between-indias-reduction-of-covid-19-cases-and-the-use-of-ivermectin-jim-hoft-gateway-pundit/

5 ( +8 / -3 )

Another scheme hatched by the genius bureaucrats to funnel taxpayers money to special interest.

It is just a pity as too often there is no mention of how much money is involved in this scheme.

True Journalism died a long time ago in this country.

4 ( +5 / -1 )

There already are treatments that are successful in curing covid. Ivermectin and Hydroxychloroquine. The shame of it all is that Ivermectin was invented by a Japanese Scientist who received the Noble Peace Prize for it. It is being used successfully in several Indian states with enormous success. Watch certain vaccine promoters do a bunk on what I have written. The use of these anti-parasite medicines would have ensured the Olympics to be held with no problem.

Exactly!

What I would like to know is how patients are treated in Japan. At the start of the pandemic, they just told anyone who tested positive to stay home and get treatment only if they had trouble breathing (much too late!!!). I really hope that is no longer the case, but I wouldn't be surprised if it still is. It would be criminal if it is...

-6 ( +2 / -8 )

Hydroxychloroquine has been proven INEFFECTIVE. How much stock in the company that makes it do you own to still be pumping it?

Ref: https://www.nih.gov/news-events/news-releases/hydroxychloroquine-does-not-benefit-adults-hospitalized-covid-19

https://www.reuters.com/article/us-health-coronavirus-hydroxychloroquine/hydroxychloroquine-ineffective-against-mild-covid-19-u-s-study-shows-idUSKCN24H2YC

https://www.bbc.com/news/world-us-canada-53575964

https://jamanetwork.com/journals/jama/fullarticle/2772922

Between a placebo and hydroxychloroquine in double-blind studies, the results were statistically the same.

Time to move on and dump your stock.

BTW, there were more ads in my web results than there were reputable sources. This is what happens in pump-n-dump scams.

4 ( +8 / -4 )

At the start of the pandemic, they just told anyone who tested positive to stay home and get treatment only if they had trouble breathing (much too late!!!). I really hope that is no longer the case, but I wouldn't be surprised if it still is. It would be criminal if it is...

It is still going on. The numbers you read here provided by the authorities doesn't reflect the reality faced

by covid-19 hospitals.

6 ( +7 / -1 )

a plan to collect data on 10,000 COVID-19 patients by next March

Why the rush?

9 ( +9 / -0 )

Hydroxychloroquine has been proven INEFFECTIVE. How much stock in the company that makes it do you own to still be pumping it?

You do realize that HCQ is dirt cheap to make, right.

From the moment that a vaccine for Covid-19 became possible, there has been a concerted rejection of several extremely safe and effective treatments.

And they are effective. But HCQ (+azithromycin) acts on the first stage of the disease, where is has a powerful effect on reducing the viral load. Hundreds of studies have confirmed its effectiveness.

There are a number of deceptive studies that were poorly designed (probably intentionally designed to fail). Like the RECOVERY trial that gave massive doses at the late stage of the disease: way too much and way too late.

Even the conclusion of your 1st reference from the NIH states:

"A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients."

Yeah, once you're hospitalized, it's too late use HCQ. And HCQ should be used together with azithromycin. Ivermectin is also effective at the early stage, but also at later stages.

-7 ( +1 / -8 )

At the start of the pandemic, they just told anyone who tested positive to stay home and get treatment only if they had trouble breathing (much too late!!!). I really hope that is no longer the case, but I wouldn't be surprised if it still is. It would be criminal if it is...

It is still going on.

Sad, and very upsetting.

-4 ( +2 / -6 )

You do realize that HCQ is dirt cheap to make, right.

So its dexamethasone, and it had no problem proving to be safe and effective, this alone demonstrate the conspiracy theory as false and irrational.

HCQ has no value in the treatment of COVID, at any stage of the disease, not even as a preventive measure. This has been so thoroughly demonstrated that the consensus of science is that HCQ should not be used for COVID, as easy to prove as no respected medical or scientific institution recommends its use.

There are a number of deceptive studies that were poorly designed (probably intentionally designed to fail). Like the RECOVERY trial that gave massive doses at the late stage of the disease: way too much and way too late.

The opposite is true, low quality studies with lots of noise appeared to hint at some use, until the noise was removed with better quality studies. Special mention is of course of the fake results pushed by Didier Raoult that had to fabricate and modify the data on his unethical studies until the studies concluded what he wanted. This is what actually means having bad studies polluting the science.

Ivermecting have shown also to be ineffective at several stages of the disease, and the experience in Brazil and other countries also point out to lack of effect even as a preventive measure. It still have a sliver of a chance of being useful (studies to investigate that are soon to be finished) but it is not likely its effect would be specially useful.

4 ( +7 / -3 )

Good idea. I hope this data can help save lives.

-5 ( +1 / -6 )

Users will need to go to the bank with their samples, passbook, and hanko. Monday to Friday, during normal business hours. There they will be given a small piece of paper with a number and asked to fill out and stamp multiple forms. Of those, half will need to be redone because katakana was in hiragana, or vice versa. Or romaji. They will then see a teller who will consult with her manager. After 30–60 minutes, the sample will be processed. The bank will then call the next day, regretful that the hiragana should have been katakana, or vice versa. Or romaji. The user will then have to go back to the bank with their hanko. 50/50 chance the sample will be entered into the database within the next month.

4 ( +4 / -0 )

Is not a good idea.

You better invest in the organizations that have been doing it for years already.

To reinvent the wheel is stupid.

5 ( +5 / -0 )

"It is very important for the state to take the lead in continuously operating the databank from the standpoint of national security," said Wataru Sugiura, who heads the Center for Clinical Sciences at the National Center for Global Health and Medicine.

If it is important, why didn't you think of this earlier? Oh right, you're one of the dinosaurs.

4 ( +4 / -0 )

Once again, our government is reinventing the wheel instead of utilising existing solutions. How about joining solutions shared by other countries? After all, the database will be populated with a larger sample of data. Wait, I think I know why not. Because foreign countries aren't compatible with hanko, faxes and absurd excel solutions.

But, what really made my day was

a plan to collect data on 10,000 COVID-19 patients by next March,

So, bit more than 2 years after Covid started in Japan.

4 ( +4 / -0 )

It is very important for the state to take the lead

Absolutely - Ganbare Nippon! Banzai! It's like an unfit 90 year-old running their first marathon. Hours after the other runners have finished, a sprinkling of spectators are still there to clap and cheer as the old geezer totters and wheezes over the line. After all, it's not about being first, it's all about showing you tried. Doesn't matter that other countries have run research, reported recommendations and these are already being used to change treatments and approaches worldwide. The important things are:

He tried. He really tried. Fighto!

As we all know, the Japanese digestive tract is shorter, so this country needs its own special study bubble.
2 ( +2 / -0 )

Seems someone else has built this already:

https://www.theverge.com/2021/7/13/22573753/covid-data-health-records-machine-learning-disease

A resource like N3C, which pulls together records from dozens of institutions, sidesteps those limitations. By now, N3C includes data from 73 health institutions and has records from over 2 million COVID-19 patients. More than 200 research projects using the data are underway, including studies examining risk factors for COVID-19 re-infection and the disease’s impact on pregnancy. It’s not perfect — standardizing information across hospitals is hard, and there may not be complete data on many patients.

And treatment modes have changed over time:

The analysis shows how treatment for COVID-19 changed over the course of 2020, as doctors tried new treatments and gained more experience with the condition. The percentage of patients who were treated with the anti-malaria drug hydroxychloroquine, which was promoted by former President Donald Trump before proving to be ineffective, dropped off to nearly zero by May 2020. Use of the steroid dexamethasone ticked up in June, after studies showed it could improve survival rates.

0 ( +0 / -0 )

Login to leave a comment

Facebook users

Use your Facebook account to login or register with JapanToday. By doing so, you will also receive an email inviting you to receive our news alerts.

Facebook Connect

Login with your JapanToday account

User registration

Articles, Offers & Useful Resources

A mix of what's trending on our other sites